Skip to main content

Advertisement

SpringerLink
Log in

Development of a new method for sampling and monitoring oncology staff exposed to cyclophosphamide drug

  • Published:
Environmental Monitoring and Assessment Aims and scope Submit manuscript

Abstract

Treatment using cytotoxic drugs is considered to be the most common treatment for cancers. However, the widespread use of these drugs on the health status of the staff at the oncology department has become a great concern. Due to challenges of sampling and analysis of cytotoxic drugs, the aim of this study was to development a novel practical method called Needle trap devices (NTD) for sampling and analysis of personal exposure to cyclophosphamide drug. The sampler consisted of a stainless steel hyper needle gauge 21 of length 9 cm packed with Carboxen 1000 for adsorbing cyclophosphamide. A total of 41 samples of staff’s air breathing zone in different wards of the oncology department were taken with the sampler. Samples were analyzed by gas chromatography coupled with electron capture detector (ECD). Linear range concentration was 212–1062 μg/m3, and LOD and LOQ were 100 and 191 μg/m3, respectively. The mean inter-day and intra-day coefficient variations for standards within linear range concentration were 8.9 and 4.8 %, respectively. Detectable levels of cyclophosphamide were measured in 31.7 % of air samples. The developed method is user-friendly, quick, and precise for sampling of airborne cyclophosphamide. The results showed that some staff of the oncology department were exposed to the carcinogenic drug and their health were at risk. Since carcinogens do not have a threshold and oncology staffs with their continuous exposure might be at risk, therefore, proper work practice and adequate control measures are essential to ensure their wellbeing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Connor, T. H., DeBord, D. G., Pretty, J. R., Oliver, M. S., Roth, T. S., Lees, P. S., et al. (2010). Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers. Journal of Occupational and Environmental Medicine, 52(10), 1019–1027.

    Article  Google Scholar 

  • Constantinidis, T., Vagka, E., Dallidou, P., Basta, P., Drakopoulos, V., Kakolyris, S., et al. (2011). Occupational health and safety of personnel handling chemotherapeutic agents in Greek hospitals. European Journal of Cancer Care, 20(1), 123–131.

    Article  CAS  Google Scholar 

  • deWerk Neal, A., Wadden, R., & Chiou, W. (1983). Exposure of hospital workers to airborne antineoplastic agents. American Journal of Health-System Pharmacy, 40(4), 597–601.

    CAS  Google Scholar 

  • Eom, I.-Y., Tugulea, A.-M., & Pawliszyn, J. (2008). Development and application of needle trap devices. Journal of Chromatography A, 1196, 3–9.

    Article  Google Scholar 

  • FDA (2001). Centre for Drug Evaluation and Research: guidance for industry: bioanalytical method validation. Food and Drug Administration.

  • Feyerherm, F., Westland, j., & Marvin, C. (2014). Quantitation and confirmation of blood ethanol content using a new GC/FID/MS blood alcohol analyzer. Agilent technologies.

  • Hedmer, M., Jonsson, B. A., & Nygren, O. (2004). Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces. Journal of Environmental Monitoring, 6(12), 979–984. doi:10.1039/b409277e.

    Article  CAS  Google Scholar 

  • Heidari, M., Bahrami, A., Ghiasvand, A. R., Shahna, F. G., & Soltanian, A. R. (2013). A needle trap device packed with a sol–gel derived, multi-walled carbon nanotubes/silica composite for sampling and analysis of volatile organohalogen compounds in air. Analytica Chimica Acta, 785, 67–74.

    Article  CAS  Google Scholar 

  • IARC (1987). Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42 (Vol. 7): World Health Organization.

  • Jochimsen, P. R. (1992). Handling of cytotoxic drugs by healthcare workers. A review of the risks of exposure. Drug Safety, 7(5), 374–380.

    Article  CAS  Google Scholar 

  • Kataoka, H., Ishizaki, A., Nonaka, Y., & Saito, K. (2009). Developments and applications of capillary microextraction techniques: a review. Analytica Chimica Acta, 655(1), 8–29.

    Article  CAS  Google Scholar 

  • Kiffmeyer, T. K., Kube, C., Opiolka, S., Schmidt, K. G., Schöppe, G., & Sessink, P. J. (2002). Vapour pressures, evaporation behaviour and airborne concentrations of hazardous drugs: implications for occupational safety. Pharmaceutical Journal, 268, 331–337.

    Google Scholar 

  • Koziel, J., Jia, M., Khaled, A., Noah, J., & Pawliszyn, J. (1999). Field air analysis with SPME device. Analytica Chimica Acta, 400(1), 153–162.

    Article  CAS  Google Scholar 

  • Larson, R. R., Khazaeli, M. B., & Dillon, H. K. (2003). A new monitoring method using solid sorbent media for evaluation of airborne cyclophosphamide and other antineoplastic agents. Applied Occupational and Environmental Hygiene, 18(2), 120–131. doi:10.1080/10473220301435.

    Article  CAS  Google Scholar 

  • Moein, M. M., Said, R., Bassyouni, F., & Abdel-Rehim, M. (2014). Solid phase microextraction and related techniques for drugs in biological samples. Journal of analytical methods in chemistry, 2014.

  • Moretti, M., Bonfiglioli, R., Feretti, D., Pavanello, S., Mussi, F., Grollino, M. G., et al. (2011). A study protocol for the evaluation of occupational mutagenic/carcinogenic risks in subjects exposed to antineoplastic drugs: a multicentric project. BMC Public Health, 11(1), 195.

    Article  Google Scholar 

  • Nygren, O., & Lundgren, C. (1997). Determination of platinum in workroom air and in blood and urine from nursing staff attending patients receiving cisplatin chemotherapy. International Archives of Occupational and Environmental Health, 70(3), 209–214.

    Article  CAS  Google Scholar 

  • Odraska, P., Dolezalova, L., Piler, P., Oravec, M., & Blaha, L. (2011). Utilization of the solid sorbent media in monitoring of airborne cyclophosphamide concentrations and the implications for occupational hygiene. Journal of Environmental Monitoring, 13(5), 1480–1487. doi:10.1039/c0em00660b.

    Article  CAS  Google Scholar 

  • Ouyang, G., & Pawliszyn, J. (2006). Recent developments in SPME for on-site analysis and monitoring. TrAC Trends in Analytical Chemistry, 25(7), 692–703.

    Article  CAS  Google Scholar 

  • Pethran, A., Hauff, K., Hessel, H., & Grimm, C. (1998). Biological, cytogenetic and ambient monitoring of exposure to antineoplastic drugs. Journal of Oncology Pharmacy Practice, 4, 57.

    Google Scholar 

  • Pretty, J. R., Connor, T. H., Spasojevic, I., Kurtz, K. S., McLaurin, J. L., B’Hymer, C., et al. (2012). Sampling and mass spectrometric analytical methods for five antineoplastic drugs in the healthcare environment. Journal of Oncology Pharmacy Practice, 18(1), 23–36. doi:10.1177/1078155210389215.

    Article  Google Scholar 

  • Sessink, P. J., & Bos, R. P. (1999). Drugs hazardous to healthcare workers. Drug Safety, 20(4), 347–359.

    Article  CAS  Google Scholar 

  • Sessink, P. J., Anzion, R. B., Van den Broek, P. H., & Bos, R. P. (1992). Detection of contamination with antineoplastic agents in a hospital pharmacy department. Pharmaceutisch Weekblad, 14(1), 16–22.

    Article  CAS  Google Scholar 

  • Sessink, P. J., Kroese, E. D., van Kranen, H. J., & Bos, R. P. (1995). Cancer risk assessment for health care workers occupationally exposed to cyclophosphamide. International Archives of Occupational and Environmental Health, 67(5), 317–323.

    Article  CAS  Google Scholar 

  • Sorsa, M., & Anderson, D. (1996). Monitoring of occupational exposure to cytostatic anticancer agents. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 355(1), 253–261.

    Article  Google Scholar 

  • Sorsa, M., Hemminki, K., & Vainio, H. (1985). Occupational exposure to anticancer drugs—potential and real hazards. Mutation Research/Reviews in Genetic Toxicology, 154(2), 135–149.

    Article  CAS  Google Scholar 

  • Sorsa, M., Pyy, L., Salomaa, S., Nylund, L., & Yager, J. W. (1988). Biological and environmental monitoring of occupational exposure to cyclophosphamide in industry and hospitals. Mutation Research/Genetic Toxicology, 204(3), 465–479.

    Article  CAS  Google Scholar 

  • Sottani, C., Turci, R., Schierl, R., Gaggeri, R., Barbieri, A., Violante, F. S., et al. (2007). Simultaneous determination of gemcitabine, taxol, cyclophosphamide and ifosfamide in wipe samples by high‐performance liquid chromatography/tandem mass spectrometry: protocol of validation and uncertainty of measurement. Rapid Communications in Mass Spectrometry, 21(7), 1289–1296.

    Article  CAS  Google Scholar 

  • Stuart, O. A., Stephens, A. D., Welch, L., & Sugarbaker, P. H. (2002). Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C. Annals of Surgical Oncology, 9(2), 186–191.

    Article  Google Scholar 

  • Wakui, N., Ookubo, T., Iwasaki, Y., Ito, R., Mitui, M., Yano, Y., et al. (2013). Determination of exposure of dispensary drug preparers to cyclophosphamide by passive sampling and liquid chromatography with tandem mass spectrometry. Journal of Oncology Pharmacy Practice, 19(1), 31–37. doi:10.1177/1078155212451196.

    Article  CAS  Google Scholar 

  • Wittgen, B. P., Kunst, P. W., Perkins, W. R., Lee, J. K., & Postmus, P. E. (2006). Assessing a system to capture stray aerosol during inhalation of nebulized liposomal cisplatin. Journal of Aerosol Medicine, 19(3), 385–391.

    Article  CAS  Google Scholar 

  • Yuan, H., Mullett, W. M., & Pawliszyn, J. (2001). Biological sample analysis with immunoaffinity solid-phase microextraction. Analyst, 126(8), 1456–1461.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from the Cancer Research Center of the Shahid Beheshti University of Medical Sciences with grant number 1958.

Author information

Authors and Affiliations

  1. School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Davood Panahi, Mansour Azari, Rezvan Zendehdel, Hossein hatami & Yadollah Mehrabi

  2. Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Mohammad Esmaeil Akbari & Hamid Reza Mirzaei

Authors
  1. Davood Panahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mansour Azari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohammad Esmaeil Akbari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rezvan Zendehdel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hamid Reza Mirzaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hossein hatami
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yadollah Mehrabi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mansour Azari.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Panahi, D., Azari, M., Akbari, M.E. et al. Development of a new method for sampling and monitoring oncology staff exposed to cyclophosphamide drug. Environ Monit Assess 188, 238 (2016). https://doi.org/10.1007/s10661-016-5255-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10661-016-5255-x

Keywords

Search

Navigation